Mohammad Ali Sheffeh, MD, from the Mayo Clinic in Rochester, Minnesota, and colleagues examined the efficacy of GLP-1 RA or SGLT-2i initiation for reducing mortality or cardiovascular events among ...

Findings seen for individuals undergoing revascularization after non-ST-segment elevation myocardial infarction ...

(HealthDay News) — There is a small inverse association between plasma omega-6 and omega-3 polyunsaturated fatty acids (PUFAs) and cancer, according to a study published online in the International ...

Extending wait time criteria from 1 to 3 hours after withdrawal of life-sustaining treatment for kidney donation after circulatory death (DCD) does not compromise kidney transplant outcomes and may ...

GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.

Preclinical studies have shown AT-02 is able to bind to multiple amyloid types and can induce macrophage mediated amyloid phagocytosis and removal. The Food and Drug Administration has granted Orphan ...

Investigators report a survival benefit with primary tumor ablation in patients with mRCC compared with no local treatment.

Fasting shows benefits compared with eating meals or snacks at night. (HealthDay News) — Fasting at night prevents impairments in glucose tolerance among simulated night-shift work, according to a ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

Findings independent of other established risk factors. (HealthDay News) — Elevated baseline resting heart rate (RHR) is associated with an increased risk for incident atrial fibrillation (AF ...

(HealthDay News) — A striking considerable number of older adults have lower-than-recommended vitamin and mineral intake, which is associated with social isolation and loneliness, according to a study ...

Supply chain issues are more likely to result in drug shortages in the United States than in Canada, data suggest.